Globe Newswire CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ( Lifecore or the Company ), a fully integrated contract development and manufacturing organization...\n more…
PR Newswire INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Lifecore INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of...\n more…
SeekingAlpha.com: All News Lifecore Biomedical, Inc. (LFCR) regains compliance with Nasdaq listing requirements, avoiding delisting action for common stock.\n more…
Globe Newswire CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ( Lifecore or the Company ), a fully integrated contract development and manufacturing organization...\n more…
PR Newswire LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit PR Newswire...\n more…
Globe Newswire Lifecore Biomedical, Inc. Class Action Lawsuit\n\n Shareholder sues Lifecore Biomedical, Inc. for making false and misleading statements\n\nSAN DIEGO, Sept. 11, 2024 (GLOBE NEWSWIRE...\n more…